Myeloid TGF-β signaling contributes to colitis-associated tumorigenesis in mice
Open Access
- 21 May 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis
- Vol. 34 (9) , 2099-2108
Abstract
Myeloid cells have a critical role in maintaining intestinal homeostasis and regulating the development of inflammatory bowel disease and colitis-associated cancer (CAC). However, the signaling pathways that control the function of colonic myeloid cells in these pathological processes are still poorly defined. In this study, we demonstrate that transforming growth factor-β (TGF-β) signaling in colonic myeloid cells is significantly involved in the development of CAC. Myeloid TGF-β receptor II (Tgfbr2)-deficient mice showed reduced susceptibility to chemically induced colitis-associated tumorigenesis, as evidenced by decreases in number and size of tumors. Myeloid Tgfbr2 deficiency markedly decreased the production of interleukin-6 and tumor necrosis factor-α, two proinflammatory cytokines that are essential for colonic tumorigenesis; in addition, a marked increase in the proportions of Foxp3 + CD4 + regulatory T cells was observed in the colonic lamina propria in the initial stage of CAC. Loss of myeloid Tgfbr2 was associated with a decrease in the presence of F4/80 positive macrophages and a downregulation of phosphorylated STAT3, proliferative cell nuclear antigen and cyclin D1 expression in colonic adenoma tissues. TGF-β enhanced macrophage recruitment, at least in part, through modulating the expression of the chemokine (C-C motif) receptor 2 (CCR2) ligands in tumor environment and the CCR2 signaling in macrophages. Collectively, these results suggest that myeloid TGF-β signaling modulates intestinal inflammation and significantly promotes tumorigenesis in the development of colitis-associated colon cancer.Keywords
This publication has 40 references indexed in Scilit:
- Cox-2 deletion in myeloid and endothelial cells, but not in epithelial cells, exacerbates murine colitis.Carcinogenesis, 2010
- Hypoxia-inducible factor 2α regulates macrophage function in mouse models of acute and tumor inflammationJournal of Clinical Investigation, 2010
- Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitisJournal of Clinical Investigation, 2008
- NF-κB: linking inflammation and immunity to cancer development and progressionNature Reviews Immunology, 2005
- IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated CancerCell, 2004
- Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Inflammation and cancerNature, 2002
- Inflammatory Bowel DiseaseNew England Journal of Medicine, 2002
- Genetic profiling of colon cancerJournal of Surgical Oncology, 2002
- The risk of colorectal cancer in ulcerative colitis: a meta-analysisGut, 2001